Hemostemix (@hemostemix) header
Hemostemix (@hemostemix) profile picture

Hemostemix is a public clinical-stage company that develops innovative blood-derived cell therapies for medical conditions not yet adequately addressed.

Calgary, Alberta, Canada
Joined March 2013
Photo by Hemostemix (@hemostemix)Photo by Hemostemix (@hemostemix)
Hemostemix Issues Corporate Update From CEO Elmar Burchardt—hemostemix.com/pages/posts/h…
1
2
1
Hemostemix Company Information Now Available Through S&P Capital IQ Corporation Records Program—hemostemix.com/pages/posts/h…
2
2
Hemostemix to Present at Phacilitate Cell & Gene Therapy World 2016 in Washington, D.C. on January 25. —hemostemix.com/pages/posts/h…
1
1
Hemostemix announced today that it has commenced trading on the OTCQX marketplace under the symbol “HMTXF.”—hemostemix.com/pages/posts/h…
2
4
Hemostemix Poised to Expand Phase-2 Clinical Trial of Lead Product ACP-01 to the United States—hemostemix.com/pages/posts/h…
1
1
Hemostemix Announces Company Updates and Attendance at the J.P. Morgan 34th Annual Healthcare Conference—hemostemix.com/pages/posts/h…
1
Hemostemix Names Jim Brown, CEO of Hemostemix Asia, Inc., to Board of Directors—hemostemix.com/pages/posts/h…
2
Hemostemix Engages Wolverton Securities Ltd. for Brokered Private Placement Offering —hemostemix.com/pages/posts/h…
1
1
Dr. Rahul Sarugaser, Hemostemix VP of corporate development, to present at 2015 Stem Cell Meeting on the Mesa—hemostemix.com/pages/posts/h…
1
Hemostemix Executes Strategic Alliance with Hemostemix Asia To Expand Phase-2 Trial for Treating CLI to Taiwan—hemostemix.com/pages/posts/h…
2
1
Hemostemix management & members of the Company's Data Safety Monitoring Board for its phase-2 clinical trial for CLI.
1
3
Hemostemix Holds First Meeting of Data Safety Monitoring Board (DSMB) for Phase-2 Clinical Trial for CLI—hemostemix.com/index.php/tra…
3
3
Hemostemix Receives FDA Clearance for Phase-2 Clinical Trial of Lead Product ACP-01 in the U.S.—hemostemix.com/index.php/tra…
2
2
Hemostemix Enrolls 20th Participant and Treats 15th in International Clinical Trial for Critical Limb Ischemia—hemostemix.com/index.php/tra…
2
2
Hemostemix forms strategic alliance in Asia for treating critical limb ischemia in Taiwan, China, and South Korea—hemostemix.com/index.php/tra…
2
2
Hemostemix Investor Road Show Hits New York, Then Heads to Boston, Chicago, and San Francisco
1
2
Hemostemix Posts Corporate Presentation on Company Website—hemostemix.com/index.php/cor…
1
1
Hemostemix Enrolls 5th Participant at Vancouver General Hospital in Phase-2 Clinical Trial for Critical Limb Ischemia—hemostemix.com/index.php/tra…
3
2
Hemostemix Prepares IND Application for U.S. FDA Review for ACP-01 to Treat Critical Limb Ischemia— hemostemix.com/index.php/tra…
1
Hemostemix and Ludwig Boltzmann Institute Enter Research Collaboration Agreement to Study Applications of ACP-01— hemostemix.com/index.php/tra…
3
2